» Articles » PMID: 26633489

Copper-2 Ingestion, Plus Increased Meat Eating Leading to Increased Copper Absorption, Are Major Factors Behind the Current Epidemic of Alzheimer's Disease

Overview
Journal Nutrients
Date 2015 Dec 4
PMID 26633489
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

It has become clear that copper toxicity is playing a major role in Alzheimer's disease; but why is the brain copper toxicity with cognition loss in Alzheimer's disease so much different clinically than brain copper toxicity in Wilson's disease, which results in a movement disorder? Furthermore, why is the inorganic copper of supplement pills and in drinking water so much more damaging to cognition than the organic copper in food? A recent paper, which shows that almost all food copper is copper-1, that is the copper-2 of foods reverts to the reduced copper-1 form at death or harvest, gives new insight into these questions. The body has an intestinal transport system for copper-1, Ctr1, which channels copper-1 through the liver and into safe channels. Ctr1 cannot absorb copper-2, and some copper-2 bypasses the liver, ends up in the blood quickly, and is toxic to cognition. Humans evolved to handle copper-1 safely, but not copper-2. Alzheimer's is at least in part, a copper-2 toxicity disease, while Wilson's is a general copper overload disease. In this review, we will show that the epidemiology of the Alzheimer's epidemic occurring in developed, but not undeveloped countries, fits with the epidemiology of exposure to copper-2 ingestion leached from copper plumbing and from copper supplement pill ingestion. Increased meat eating in developed countries is also a factor, because it increases copper absorption, and thus over all copper exposure.

Citing Articles

Copper homeostasis and neurodegenerative diseases.

Wang Y, Li D, Xu K, Wang G, Zhang F Neural Regen Res. 2024; 20(11):3124-3143.

PMID: 39589160 PMC: 11881714. DOI: 10.4103/NRR.NRR-D-24-00642.


The Effects of Fisetin and Curcumin on Oxidative Damage Caused by Transition Metals in Neurodegenerative Diseases.

Bjorklund G, Oliinyk P, Khavrona O, Lozynska I, Lysiuk R, Darmohray R Mol Neurobiol. 2024; 62(1):1225-1246.

PMID: 38970766 DOI: 10.1007/s12035-024-04321-2.


Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds.

Zhong G, Wang X, Li J, Xie Z, Wu Q, Chen J Curr Neuropharmacol. 2023; 22(10):1650-1671.

PMID: 38037913 PMC: 11284712. DOI: 10.2174/1570159X22666231103085859.


Diet's Role in Modifying Risk of Alzheimer's Disease: History and Present Understanding.

Grant W, Blake S J Alzheimers Dis. 2023; 96(4):1353-1382.

PMID: 37955087 PMC: 10741367. DOI: 10.3233/JAD-230418.


Design and Development of Inexpensive Paper-Based Chemosensors for Detection of Divalent Copper.

Geetha M, Sadasivuni K, Al-Ejji M, Sivadas N, Bhattacharyya B, Musthafa F J Fluoresc. 2023; 33(6):2327-2338.

PMID: 37036631 PMC: 10640528. DOI: 10.1007/s10895-023-03220-4.


References
1.
Chartier-Harlin M, Crawford F, Houlden H, Warren A, Hughes D, Fidani L . Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature. 1991; 353(6347):844-6. DOI: 10.1038/353844a0. View

2.
James S, Volitakis I, Adlard P, Duce J, Masters C, Cherny R . Elevated labile Cu is associated with oxidative pathology in Alzheimer disease. Free Radic Biol Med. 2011; 52(2):298-302. DOI: 10.1016/j.freeradbiomed.2011.10.446. View

3.
Squitti R, Polimanti R, Bucossi S, Ventriglia M, Mariani S, Manfellotto D . Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's disease. Rejuvenation Res. 2012; 16(1):3-10. PMC: 3582274. DOI: 10.1089/rej.2012.1357. View

4.
Hardy J, Selkoe D . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002; 297(5580):353-6. DOI: 10.1126/science.1072994. View

5.
Sparks D, Friedland R, Petanceska S, Schreurs B, Shi J, Perry G . Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology. J Nutr Health Aging. 2006; 10(4):247-54. PMC: 3899576. View